-
Published 8/30/2024
Wesselink AK, Claus Henn B, Fruh V, Geller RJ, Coleman CM, Schildroth S, Sjodin A, Bethea TN, Noel NL, Baird DD, Wegienka G, Wise LA. Persistent endocrine-disrupting chemicals and incident uterine leiomyomata: A mixtures analysis. Sci Total Environ. 2024 Nov 15; 951:175871. PMID: 39216750.
-
Published 6/24/2024
Wise LA, Coleman CM, Schildroth S, Geller RJ, Lovett SM, Claus Henn B, Calafat AM, Botelho JC, Marsh EE, Noel N, Wegienka GR, Bethea TN, Harmon QE, Baird DD, Wesselink AK. Associations of per- and polyfluoroalkyl substances with uterine leiomyomata incidence and growth: a prospective ultrasound study. J Expo Sci Environ Epidemiol. 2024 Jun 24. PMID: 38914782.
-
Published 5/3/2024
Jarmoc G, Smith C, Finnerty E, Noel NL, Marks A. Anti-NMDA encephalitis secondary to an ovarian teratoma presenting as altered mental status in a 32-year-old woman: A case report. Case Rep Womens Health. 2024 Jun; 42:e00612. PMID: 38737718.
-
Published 4/1/2024
Noel NL, Abrams J, Mudafort ER, Babu A, Forbes E, Hill L, Hill CC, Valbrun TG, Osian N, Wise LA, Kuohung W. Study protocol for the implementation of Centering Patients with Fibroids, a novel group education and empowerment program for patients with symptomatic uterine fibroids. Reprod Health. 2024 Apr 01; 21(1):41. PMID: 38561795.
-
Published 5/4/2023
Wesselink AK, Wegienka G, Coleman CM, Geller RJ, Harmon QE, Upson K, Lovett SM, Claus Henn B, Marsh EE, Noel NL, Baird DD, Wise LA. A prospective ultrasound study of cigarette smoking and uterine leiomyomata incidence and growth. Am J Obstet Gynecol. 2023 Aug; 229(2):151.e1-151.e8. PMID: 37148957.